| Literature DB >> 28129644 |
Maurice Pasternak1,2, Lilian Doss1,3, Golnaz Farhat1,3,4, Azza Al-Mahrouki1,3, Christina Hyunjung Kim1,3, Michael Kolios2, William Tyler Tran1,5, Gregory J Czarnota1,3,4,5.
Abstract
High-frequency ultrasound (~20 MHz) techniques were investigated using in vitro and ex vivo models to determine whether alterations in chromatin structure are responsible for ultrasound backscatter changes in biological samples. Acute myeloid leukemia (AML) cells and their isolated nuclei were exposed to various chromatin altering treatments. These included 10 different ionic environments, DNA cleaving and unfolding agents, as well as DNA condensing agents. Raw radiofrequency (RF) data was used to generate quantitative ultrasound parameters from spectral and form factor analyses. Chromatin structure was evaluated using electron microscopy. Results indicated that trends in quantitative ultrasound parameters mirrored trends in biophysical chromatin structure parameters. In general, higher ordered states of chromatin compaction resulted in increases to ultrasound paramaters of midband fit, spectral intercept, and estimated scatterer concentration, while samples with decondensed forms of chromatin followed an opposite trend. Experiments with isolated nuclei demonstrated that chromatin changes alone were sufficient to account for these observations. Experiments with ex vivo samples indicated similar effects of chromatin structure changes. The results obtained in this research provide a mechanistic explanation for ultrasound investigations studying scattering from cells and tissues undergoing biological processes affecting chromatin.Entities:
Keywords: chromatin; electron microscopy; form-factor analysis; spectral analysis; ultrasound
Mesh:
Substances:
Year: 2017 PMID: 28129644 PMCID: PMC5386710 DOI: 10.18632/oncotarget.14816
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Figure 1A. Representative electron microscopy images of fixed AML-5 cells subjected to varying concentrations of sodium chloride. Top row panels depict whole cell morphology. Bottom panels depict chromatin strucutre at high magnification for each salinity. The scale bar in the top row represents 2 microns. The lower scale bar represents 100 nm. B. Light microscopy (top row) and corresponding color-coated B-mode ultrasound images of non-fixed cell samples. Cell and nuclear size changes differ from electron microscopy due to no fixation step prior to imaging. Speckle intensity is illustrated through pixel color, with dark red representing less scattering and white representing increased scattering. The scale bar in light microscopy images represents 6 microns. The scale bar in ultrasound B-mode images represents 1 mm.
Figure 2Quantitative data dervied from spectral ultrasound analysis, electron miscropy analysis, and ultrasound form factor analysis
Results of relative A. mid-band fit, B. spectral intercept, and C. estimated acoustic concentration for whole cells subjected to sodium concentrations from 1/16X salinity to 32X salinity. Observed trends corresponded strongly to an D. index of chromatin condensation based on quantifying the number of 30 nm strands and larger chromatin clusters per high-powered field and multiplying by a scaling factor for clearer data presentation. E. Results from the spectral slope parameter were not signficantly different, corresponding to statistically-similar values for F. estimated scatterer diameter throughout all salinities. G. Measured sizes of nuclear diameter and H. cellular diameter did demonstrate trends of increasing size for lower salt concentrations, but did not appear to affect spectral slope or estimated scatterer diameter. Error bars represent SD at n ≥ 4.
Figure 3Representative results from sodium butyrate treatment of in vitro samples
A. B-mode images indicated decreases in ultrasound backscatter, corresponding to decreases in B. midband fit, C. spectral intercept, and D. estimated acoustic concentration. E. Electron microscopy images depict signficant alterations in chromatin structure, indicating a decrease in chromatin compaction. Selected regions of higher maginifcation are represented by squares on lower magnificaion panels. F. Quantified counts of the number of 30 nm strands and G. larger chromatin clusters per high-powered field. H. Spectral slope and I. estimated scatterer diameter measurements demonstrated slight changes as a function of treatment. ** and *** indicate p<0.01 and p<0.001, respectively, for n ≥ 4 samples. The scale bar in B-mode images represents 1 mm. Scale bars for low-magnification and high-magnification electron micrscopy images correspond to 2 βm and 100 nm, respectively.
Figure 4Representative mid-band fit data from other chromatin-altering treatments
A. Results from DNase I, colchicine and cisplatinum treatments, indicating that conditions inducing chromatin condensation were sufficient to increase midband fit. A significant difference was determined to exist between colchicine and cisplatinum treatment. B. Results from isolated nuclei experiments involving cisplatinum treatment. Both isolated nuclei and whole cells demonstrated increased midband fit values after exposure to cisplatinum. Untreated control nuclei demonstrated a significantly higher midband fit value than untreated whole cells. *** indicates p<0.001 between the indicated condition and the corresponding untreated control. † indicates p<0.05 significance between colchicine and cisplatinum treatments. ## indicates p<0.01 significance between untreated nuclei and untreated whole cells. n ≥ 4 for all conditions.
Figure 5Imaging of DNase I treatment in excised mouse liver
A. B-mode images of control (left) and 1 hour DNase I- treated samples (right). Darker pixels correspond to lower levels of ultrasound scattering and white representing regions of increased ultrasound scattering levels. B. When quantified to determine backscatter intensity, DNase I treatment results in signficant decreases to sample echogenecity. ** indicates p<0.01 statistical significance for n=4 measurements. Scale bar represents 0.5 mm.